Literature DB >> 3053565

Spiramycin concentrations in the human respiratory tract: a review.

E Bergogne-Bérézin1.   

Abstract

Spiramycin has exceptionally good distribution properties, especially in respiratory tract tissues and fluids. Three hours after a single oral dose of 3 g spiramycin, the serum concentration ranged from 1.6 to 2.8 mg/l and the reported half-life was approximately 8 h. Studies of lung tissue concentrations showed that high pulmonary levels were achieved after a loading dose of 3 g; the levels were higher after multiple doses and reached approximately 30 to 45 mg/kg in lung tissue and 6.5 to 36 mg/kg in bronchial mucosa; in bronchial secretions and in sputum the concentrations of spiramycin ranged from 1.5 to 7.3 mg/l (after 1 g, multiple doses). In upper respiratory tract tissues and fluids, high levels of spiramycin were reached as well: 8 to 13 mg/kg in sinus mucosa; 15 to 29.5 mg/kg in tonsils or adenoids.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3053565     DOI: 10.1093/jac/22.supplement_b.117

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  3 in total

Review 1.  Pharmacodynamics and pharmacokinetics of spiramycin and their clinical significance.

Authors:  I Brook
Journal:  Clin Pharmacokinet       Date:  1998-04       Impact factor: 6.447

2.  Pharmacokinetics of spiramycin in the rhesus monkey: transplacental passage and distribution in tissue in the fetus.

Authors:  E Schoondermark-Van de Ven; J Galama; W Camps; T Vree; F Russel; J Meuwissen; W Melchers
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

3.  Efficacy of spiramycin as an alternative to amoxicillin in the treatment of acute upper respiratory tract infections.

Authors:  C Bunnag; P Jareoncharsri; S Voraprayoon; A Vitavasiri; P Supatchaipisit; S Kongpatanakul
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.